Evaluation of prognostic markers in severe drug-induced liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

267

HTML

1159

Tables (1-5)

240

Sum=1666

Jan 28, 2007 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 28, 2007; 13(4): 628-632
Published online Jan 28, 2007. doi: 10.3748/wjg.v13.i4.628

Table 3 Comparison between died and recovered patients with hepatocellular injury or with cholestatic/mixed liver injury

The laboratory parameters are all peak values. Results are expressed as mean ± SD or medians.

^aP < 0.05,

^bP < 0.001 vs the control group.

Citation: Li B, Wang Z, Fang JJ, Xu CY, Chen WX. Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol 2007; 13(4): 628-632
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/628.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i4.628